118 related articles for article (PubMed ID: 38073490)
1. Colorectal cancer subtyping and prognostic model construction based on interleukin-related genes.
Song J; Chen J; Chen Y; Wang Y; Zheng L; Yu H; Chen C
Physiol Genomics; 2024 May; 56(5):367-383. PubMed ID: 38073490
[TBL] [Abstract][Full Text] [Related]
2. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
3. Subtyping and prognostic model construction based on vesicle-mediated transport-related genes in colorectal cancer.
Wu W; Huang T; Li S; Gong G; Zhao D; Qiu Y
Hum Mol Genet; 2024 Feb; 33(6):478-490. PubMed ID: 37971354
[TBL] [Abstract][Full Text] [Related]
4. Identification and analysis of a CD8+ T cell-related prognostic signature for colorectal cancer based on bulk RNA sequencing and scRNA sequencing data: A STROBE-compliant retrospective study.
Pan Z; Li Q; Feng Y; Gao C; Pan F
Medicine (Baltimore); 2022 Sep; 101(39):e30758. PubMed ID: 36181098
[TBL] [Abstract][Full Text] [Related]
5. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel Immune-Related prognostic model for patients with colorectal cancer based on 3 subtypes.
Yang X; Wei Q
Immunobiology; 2023 Mar; 228(2):152352. PubMed ID: 36827833
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
8. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients.
Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B
Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161
[TBL] [Abstract][Full Text] [Related]
10. Construction of a New Ferroptosis-related Prognosis Model for Survival Prediction in Colorectal Cancer.
Chen L; Ge M; Mo S; Shi M; Zhang J; Liu J
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38362684
[TBL] [Abstract][Full Text] [Related]
11. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6.
Jiang L; Zhao XH; Mao YL; Wang JF; Zheng HJ; You QS
J Exp Clin Cancer Res; 2019 Nov; 38(1):465. PubMed ID: 31718693
[TBL] [Abstract][Full Text] [Related]
13. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
[TBL] [Abstract][Full Text] [Related]
14. Unraveling a novel hippo-associated immunological prognostic signature: The contribution of SERPINE1 in facilitating colorectal cancer progression via the notch signaling pathway.
Su X; Wang X; Lai J; Mao S; Li H
Genomics; 2024 Mar; 116(2):110794. PubMed ID: 38224823
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression of tumor-infiltrating CD8
Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653
[TBL] [Abstract][Full Text] [Related]
16. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer.
Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L
Front Genet; 2023; 14():1186862. PubMed ID: 37323657
[No Abstract] [Full Text] [Related]
17. Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer.
Chen DY; Zhang YY; Nie HH; Wang HZ; Qiu PS; Wang F; Peng YN; Xu F; Zhao Q; Zhang M
Sci Rep; 2024 Feb; 14(1):4459. PubMed ID: 38396064
[TBL] [Abstract][Full Text] [Related]
18. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of the Glycolysis and Immune-related Gene Signature for Prognosis in Colorectal Cancer.
Jiang M; Liu Y; Xu J; Xu Z; Ye T; Li S; Jiang C
Anticancer Res; 2024 Jan; 44(1):117-131. PubMed ID: 38159970
[TBL] [Abstract][Full Text] [Related]
20. Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer.
Huang Y; Yin D; Wu L
Sci Rep; 2022 Oct; 12(1):17348. PubMed ID: 36253436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
